About this trial
The aim of this project is to perform a detailed evaluation of upper esophageal sphincter function and the swallowing mechanism in patients with swallowing disorders or suspected extraesophageal reflux using high-resolution manometry with impedance and 24-hour pH-impedance monitoring.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age 18-75 years
patients with swallowing difficulties suspected of having a functional oesophageal disorder or patients with clinical signs of extra-oesophageal reflux (Reflux Symptom Index [RSI] ≥ 13 or Reflux Symptom Score-12 [RSS-12] ≥ 11) signed informed consent
Disqualifiers
patients with a diagnosed tumor of the esophagus or upper airway, or with strong clinical suspicion of a tumor of the esophagus or upper airway
severe neurological disease affecting swallowing
pregnancy
surgery involving the head, neck, or esophagus within the last 6 months
Trial design
Parallel
Treatments tested in this trial
High resolution oesophageal manometry with impedance
Diagnostic testPatients with extraoesophageal reflux and dysphagia will undergo high resolution oesophageal manometry with impedance.
24-hour pH metry
Diagnostic testPatients with extraoesophageal reflux will undergo 24-hour pH-metry.
Treatment groups
Trial outcomes
Primary outcomes
PAET (Proximal Acid Exposure Time)
PAET (Proximal Acid Exposure Time) - acid exposure to the proximal oesophageus will be measured in per cent of the whole 24-h period.
Upper esophageal sphincter (UES) Integrated Relaxation Pressure (IRP)
UES IRP is a measure of the extent of UES relaxation measured in mmHg
UES Maximum Admittance
UES MaxAd is the highest admittance value recorded during trans-sphincteric bolus flow measured in milliseconds.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: